Skip to Main Content

Paper Details

Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients.
medRxiv
2
2023
AR, Androgen, Androgen Receptor, Enhancer, H3K27ac, H3K27ac-differentially marked regions, HDAC, HDAC3, PDX, cell lines, enhancer/promoter, enzalutamide, mCRPC, metastatic castration-resistant prostate cancer, patient, patients, vorinostat

Datasets